Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 6/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 7/20 | 0.36 |
| ▸ | ACACB | O00763 | 1/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.34 |
| ▸ | TIPARP | Q7Z3E1 | 1/20 | 0.34 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23744338 | 0.86 | TRPV1 (0.42) | SMN1; SMN2CHRM2CHRM1CHRM3CHRM4 | |
| SCHEMBL26089136 | 0.86 | TRPV1 (0.42) | SMN1; SMN2CHRM2CHRM1CHRM3CHRM4 | |
| SCHEMBL26087204 | 0.75 | CHRM2 (0.55) | CHRM2CHRM1CHRM3CHRM4 | |
| SCHEMBL26087301 | 0.74 | TRPV1 (0.43) | CHRM2CHRM1CHRM3CHRM4ACACB | |
| SCHEMBL29165925 | 0.74 | TRPV1 (0.43) | CHRM2CHRM1CHRM3CHRM4ACACB | |
| SCHEMBL26089036 | 0.74 | TRPV1 (0.43) | CHRM2CHRM1CHRM3CHRM4ACACB | |
| SCHEMBL27233838 | 0.74 | TRPV1 (0.43) | CHRM2CHRM1CHRM3CHRM4ACACB | |
| SCHEMBL23728061 | 0.74 | TRPV1 (0.43) | CHRM2CHRM1CHRM3CHRM4ACACB | |
| SCHEMBL29165969 | 0.74 | TRPV1 (0.43) | CHRM2CHRM1CHRM3CHRM4ACACB | |
| SCHEMBL23744341 | 0.70 | CHRM2 (0.52) | SMN1; SMN2CHRM2CHRM1CHRM3CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021158698-A1 | MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE | NEUROCRINE BIOSCIENCES, INC. (US) | 2021-08-12 | — | — | WO | disclosed |